文献速递前列腺癌

Grade Group系统较Gleason评分风险分组更准确预测前列腺癌病理与早期肿瘤学结局

Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.
PubMed 文献 · J Urol · 2019-01-01

基于MUSIC协作组2012年3月至2017年6月接受穿刺活检及根治性前列腺切除术的8,052例患者数据,比较GG与GS风险分组对病理结局和复发的预测效能。结果显示活检GG 3 vs 2及GG 5 vs 4显著预测前列腺外侵犯、精囊侵犯和淋巴结阳性(p<0.001),活检GG 3、4、5较下一级GG生化复发时间更短(p<0.001),根治术后GG 3、4、5亦与更高复发概率相关(p<0.001);GG对上述结局的预测力优于GS。

要点

  • 活检GG 3 vs 2及GG 5 vs 4显著预测前列腺外侵犯、精囊侵犯和淋巴结阳性(p<0.001)。
  • 活检GG 3、4、5较下一级GG生化复发时间更短(p<0.001)。
  • GG对前列腺外侵犯、精囊侵犯、淋巴结阳性和生化复发的预测力优于GS风险分组。

核心结论

  • 活检及根治术后GG较GS风险分组能更好区分各风险组间的无复发生存,GG 2、3、4、5逐级与风险增加相关。

研究设计与样本

  • 基于MUSIC协作组数据的比较研究,纳入2012年3月至2017年6月接受穿刺活检及根治性前列腺切除术的8,052例患者,按GG和GS分类,采用逻辑回归和Cox回归比较结局。

主要发现

  • 控制患者特征后,活检GG 3 vs 2及GG 5 vs 4的前列腺外侵犯、精囊侵犯和淋巴结阳性风险显著更高(p<0.001)。
  • 活检GG 3、4、5较下一级GG生化复发时间更短(p<0.001)。
  • 根治术后GG 3、4、5各较下一级GG复发概率更高(p<0.001)。
  • GG较GS对前列腺外侵犯、精囊侵犯、淋巴结阳性和生化复发的预测力更好。

临床怎么用

  • 在前列腺癌风险分层中可优先采用GG系统替代GS风险分组,以更准确预测病理分期和早期生化复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The GG (Grade Group) system was introduced in 2013. Data from academic centers suggest that GG better distinguishes between prostate cancer risk groups than the Gleason score (GS) risk groups. We compared the performance of the 2 systems to predict pathological/recurrence outcomes using data from the MUSIC (Michigan Urological Surgery Improvement Collaborative). MATERIALS AND METHODS: Patients who underwent biopsy and radical prostatectomy in the MUSIC from March 2012 to June 2017 were classified according to GG and GS. Outcomes included the presence or absence of extraprostatic extension, seminal vesical invasion, positive lymph nodes, positive surgical margins and time to cancer recurrence (defined as postoperative prostate specific antigen 0.2 ng/ml or greater). Logistic and Cox regression models were used to compare the difference in outcomes. RESULTS: A total of 8,052 patients were identified. When controlling for patient characteristics, significantly higher risks of extraprostatic extension, seminal vesical invasion and positive lymph nodes were observed for biopsy GG 3 vs 2 and for GG 5 vs 4 (p <0.001). Biopsy GGs 3, 4 and 5 also showed shorter time to biochemical recurrence than GGs 2, 3 and 4, respectively (p <0.001). GGs 3, 4 and 5 at radical prostatectomy were each associated with a greater probability of recurrence compared to the next lower GG (p <0.001). GG (vs GS) had better predictive power for extraprostatic extension, seminal vesical invasion, positive lymph nodes and biochemical recurrence. CONCLUSIONS: GG at biopsy and radical prostatectomy allows for better discrimination of recurrence-free survival between individual risk groups than GS risk groups with GGs 2, 3, 4 and 5 each incrementally associated with increased risk.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Kirmiz S, Qi J, Babitz SK, et al. Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups. J Urol. 2019. PMID: 30195846. doi:10.1016/j.juro.2018.08.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。